Literature DB >> 16511036

A C-terminal segment of the V1R vasopressin receptor is unstructured in the crystal structure of its chimera with the maltose-binding protein.

Nallini Vijayarangan Adikesavan1, Syed Saad Mahmood, Nithianantham Stanley, Zhen Xu, Nan Wu, Marc Thibonnier, Menachem Shoham.   

Abstract

The V1 vascular vasopressin receptor (V1R) is a G-protein-coupled receptor (GPCR) involved in the regulation of body-fluid osmolality, blood volume and blood pressure. Signal transduction is mediated by the third intracellular loop of this seven-transmembrane protein as well as by the C-terminal cytoplasmic segment. A chimera of the maltose-binding protein (MBP) and the C-terminal segment of V1R has been cloned, expressed, purified and crystallized. The crystals belong to space group P2(1), with unit-cell parameters a = 51.10, b = 66.56, c = 115.72 A, beta = 95.99 degrees. The 1.8 A crystal structure reveals the conformation of MBP and part of the linker region of this chimera, with the C-terminal segment being unstructured. This may reflect a conformational plasticity in the C-terminal segment that may be necessary for proper function of V1R.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16511036      PMCID: PMC1952416          DOI: 10.1107/S1744309105007293

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  14 in total

Review 1.  The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists.

Authors:  M Thibonnier; P Coles; A Thibonnier; M Shoham
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

2.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

3.  Role of the human V1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction.

Authors:  M Thibonnier; C L Plesnicher; K Berrada; L Berti-Mattera
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-07       Impact factor: 4.310

Review 4.  Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm.

Authors:  P E Wright; H J Dyson
Journal:  J Mol Biol       Date:  1999-10-22       Impact factor: 5.469

5.  Inherent protein structural flexibility at the RNA-binding interface of L30e.

Authors:  Jeffrey A Chao; G S Prasad; Susan A White; C David Stout; James R Williamson
Journal:  J Mol Biol       Date:  2003-02-28       Impact factor: 5.469

6.  Dynamic interaction of human vasopressin/oxytocin receptor subtypes with G protein-coupled receptor kinases and protein kinase C after agonist stimulation.

Authors:  K Berrada; C L Plesnicher; X Luo; M Thibonnier
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

7.  Structural evidence for a dominant role of nonpolar interactions in the binding of a transport/chemosensory receptor to its highly polar ligands.

Authors:  Xiaoqun Duan; Florante A Quiocho
Journal:  Biochemistry       Date:  2002-01-22       Impact factor: 3.162

8.  Crystal structure of the SarR protein from Staphylococcus aureus.

Authors:  Y Liu; A Manna; R Li; W E Martin; R C Murphy; A L Cheung; G Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

9.  Molecular pharmacology of human vasopressin receptors.

Authors:  M Thibonnier; D M Conarty; J A Preston; P L Wilkins; L N Berti-Mattera; R Mattera
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

Review 10.  Crystal structures of fusion proteins with large-affinity tags.

Authors:  Douglas R Smyth; Marek K Mrozkiewicz; William J McGrath; Pawel Listwan; Bostjan Kobe
Journal:  Protein Sci       Date:  2003-07       Impact factor: 6.725

View more
  1 in total

Review 1.  Crystal structures of MBP fusion proteins.

Authors:  David S Waugh
Journal:  Protein Sci       Date:  2016-01-09       Impact factor: 6.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.